107 related articles for article (PubMed ID: 3985061)
1. Survival of nonsurgically staged patients with negative lymphangiograms who had Stage IIB carcinoma of the cervix treated by pelvic radiation plus hydroxyurea.
Piver MS; Krishnamsetty RM; Emrich LJ
Am J Obstet Gynecol; 1985 Apr; 151(8):1006-8. PubMed ID: 3985061
[TBL] [Abstract][Full Text] [Related]
2. Hydroxyurea plus pelvic radiation versus placebo plus pelvic radiation in surgically staged stage IIIB cervical cancer.
Piver MS; Vongtama V; Emrich LJ
J Surg Oncol; 1987 Jun; 35(2):129-34. PubMed ID: 3108586
[TBL] [Abstract][Full Text] [Related]
3. Hydroxyurea plus pelvic irradiation versus placebo plus pelvic irradiation in nonsurgically staged stage IIIB cervical cancer.
Piver M; Khalil M; Emrich LJ
J Surg Oncol; 1989 Oct; 42(2):120-5. PubMed ID: 2796346
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20.
Rotman M; Pajak TF; Choi K; Clery M; Marcial V; Grigsby PW; Cooper J; John M
JAMA; 1995 Aug; 274(5):387-93. PubMed ID: 7616634
[TBL] [Abstract][Full Text] [Related]
5. A randomized trial of hydroxyurea versus misonidazole adjunct to radiation therapy in carcinoma of the cervix. A preliminary report of a Gynecologic Oncology Group study.
Stehman FB; Bundy BN; Keys H; Currie JL; Mortel R; Creasman WT
Am J Obstet Gynecol; 1988 Jul; 159(1):87-94. PubMed ID: 3293456
[TBL] [Abstract][Full Text] [Related]
6. Hydroxyurea: a radiation potentiator in carcinoma of the uterine cervix. A randomized double-blind study.
Piver MS; Barlow JJ; Vongtama V; Blumenson L
Am J Obstet Gynecol; 1983 Dec; 147(7):803-8. PubMed ID: 6359885
[TBL] [Abstract][Full Text] [Related]
7. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Morris M; Eifel PJ; Lu J; Grigsby PW; Levenback C; Stevens RE; Rotman M; Gershenson DM; Mutch DG
N Engl J Med; 1999 Apr; 340(15):1137-43. PubMed ID: 10202164
[TBL] [Abstract][Full Text] [Related]
8. Hydroxyurea as a radiation sensitizer in women with carcinoma of the uterine cervix.
Piver MS; Barlow JJ; Vongtama V; Blumenson L
Am J Obstet Gynecol; 1977 Oct; 129(4):379-83. PubMed ID: 410296
[TBL] [Abstract][Full Text] [Related]
9. Treatment of advanced invasive cervical cancer: changing times and trends.
Yoonessi M
J Surg Oncol; 1984 Jul; 26(3):161-7. PubMed ID: 6234434
[TBL] [Abstract][Full Text] [Related]
10. Severe radiation morbidity in carcinoma of the cervix: impact of pretherapy surgical staging and previous surgery.
Fine BA; Hempling RE; Piver MS; Baker TR; McAuley M; Driscoll D
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):717-23. PubMed ID: 7860382
[TBL] [Abstract][Full Text] [Related]
11. Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion.
Huguet F; Cojocariu OM; Levy P; Lefranc JP; Darai E; Jannet D; Ansquer Y; Lhuillier PE; Benifla JL; Seince N; Touboul E
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1508-15. PubMed ID: 18676093
[TBL] [Abstract][Full Text] [Related]
12. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.
Eifel PJ; Winter K; Morris M; Levenback C; Grigsby PW; Cooper J; Rotman M; Gershenson D; Mutch DG
J Clin Oncol; 2004 Mar; 22(5):872-80. PubMed ID: 14990643
[TBL] [Abstract][Full Text] [Related]
13. Cervical cancer: combined modality therapy.
Grigsby PW
Cancer J; 2001; 7 Suppl 1():S47-50. PubMed ID: 11504285
[TBL] [Abstract][Full Text] [Related]
14. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Rose PG; Bundy BN; Watkins EB; Thigpen JT; Deppe G; Maiman MA; Clarke-Pearson DL; Insalaco S
N Engl J Med; 1999 Apr; 340(15):1144-53. PubMed ID: 10202165
[TBL] [Abstract][Full Text] [Related]
15. Para-aortic involvement and interest of para-aortic lymphadenectomy after chemoradiation therapy in patients with stage IB2 and II cervical carcinoma radiologically confined to the pelvic cavity.
Delpech Y; Haie-Meder C; Rey A; Zafrani Y; Uzan C; Gouy S; Pautier P; Lhommé C; Duvillard P; Castaigne D; Morice P
Ann Surg Oncol; 2007 Nov; 14(11):3223-31. PubMed ID: 17713822
[TBL] [Abstract][Full Text] [Related]
16. [Standards, options and recommendations: concomitant radiochemotherapy for cancer of the cervix: a critical analysis of the literature and update of SOR].
Haie-Meder C; Fervers B; Chauvergne J; Fondrinier E; Lhommé C; Guastalla JP; Resbeut M
Bull Cancer; 1999 Oct; 86(10):829-41. PubMed ID: 10572234
[TBL] [Abstract][Full Text] [Related]
17. Hydroxyurea, 5-fluorouracil infusion, and cisplatin adjunct to radiation therapy in cervical carcinoma: a phase I-II trial of the Gynecologic Oncology Group.
Stehman FB; Bundy BN; Kucera PR; Deppe G; Reddy S; O'Connor DM
Gynecol Oncol; 1997 Aug; 66(2):262-7. PubMed ID: 9264574
[TBL] [Abstract][Full Text] [Related]
18. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
[TBL] [Abstract][Full Text] [Related]
19. [Locally advanced carcinoma of the cervix uteri (stage IIB-IIIB TNM-UICC): radiotherapy combined with simultaneous daily low-dose platinum. Phase II study].
Micheletti E; La Face B; Bianchi E; Cagna E; Sartori E
Radiol Med; 1996 May; 91(5):628-34. PubMed ID: 8693131
[TBL] [Abstract][Full Text] [Related]
20. [Preoperative concurrent radiation therapy and chemotherapy for operable bulky carcinomas of uterine cervix stages IB2, IIA, and IIB with proximal parametrial invasion].
Lerouge D; Touboul E; Lefranc JP; Uzan S; Jannet D; Moureau-Zabotto L; Genestie C; Antoine M; Jamali M
Cancer Radiother; 2004 Jun; 8(3):168-77. PubMed ID: 15217584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
